|
|
|
Volumn 52, Issue 2, 2004, Pages 136-144
|
|
Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL TYROSINE KINASE;
BCR-ABL TYROSINE KINASE;
ENZYME INHIBITOR;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
CHRONIC MYELOID LEUKEMIA;
DRUG ANTAGONISM;
ENZYMOLOGY;
GENE TRANSLOCATION;
GENETICS;
HUMAN;
PHASE 3 CLINICAL TRIAL;
PHILADELPHIA 1 CHROMOSOME;
REVIEW;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE III;
ENZYME INHIBITORS;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
PHILADELPHIA CHROMOSOME;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
TRANSLOCATION, GENETIC;
|
|
EID: 2542549683
PISSN: 00471860
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (30)
|
